Myriad Genetics, Inc.

Historical 13F Holders

Symbol
MYGN
CUSIP
62855J104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 62855J104 since 12/18/2024, newest first.

Filer % of Class Filed
BlackRock Portfolio Management LLC 13G 10.4% 9/4/2026
Event 8/31/2026
Glenview Capital Management, LLC 13G/A Amendment 1
0% 8/14/2026
Event 6/30/2026
Vestal Point Capital, LP 13G
6.1% 8/14/2026
Event 6/30/2026
State Street Corp 13G 5.3% 8/7/2026
Event 6/30/2026
State Street Corp 13G 4.7% 5/12/2026
Event 3/31/2026
BlackRock, Inc. 13G/A Amendment 5 8.5% 4/7/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 14 0% 3/27/2026
Event 3/13/2026
Integrated Core Strategies (US) LLC 13G/A Amendment 3
7.2% 2/11/2026
Event 12/31/2025
State Street Corp 13G 6.4% 2/9/2026
Event 12/31/2025
Glenview Capital Management, LLC 13G
5.3% 1/13/2026
Event 1/6/2026
Integrated Core Strategies (US) LLC 13G/A Amendment 2
5.1% 11/12/2025
Event 9/30/2025
Barclays PLC 13G/A Amendment 1 4.2% 11/12/2025
Event 9/30/2025
Vanguard Group Inc 13G/A Amendment 13 8.5% 10/31/2025
Event 9/30/2025
Disciplined Growth Investors Inc /MN 13G/A Amendment 1 0.8% 8/14/2025
Event 6/30/2025
Wellington Management Group LLP 13G/A Amendment 5
0% 8/12/2025
Event 6/30/2025
Barclays PLC 13G 5.3% 8/12/2025
Event 6/30/2025
Integrated Core Strategies (US) LLC 13G/A Amendment 1
5.3% 8/4/2025
Event 6/30/2025
Vanguard Group Inc 13G/A Amendment 12 10.0% 7/29/2025
Event 6/30/2025
BlackRock, Inc. 13G/A Amendment 4 15.3% 7/17/2025
Event 6/30/2025
Disciplined Growth Investors Inc /MN 13G 5.1% 5/15/2025
Event 3/31/2025
Wellington Management Group LLP 13G/A Amendment 4
5.0% 5/12/2025
Event 3/31/2025
Camber Capital Management LP 13G/A Amendment 3
3.4% 2/14/2025
Event 12/31/2024
Wellington Management Group LLP 13G/A Amendment 3
6.6% 2/10/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 17.9 k $77.1 k
2026 Q2 202 90.0 M $515 M
2026 Q1 207 213 M $520 M
2025 Q4 224 92.2 M $568 M
2025 Q3 230 89.1 M $644 M
2025 Q2 229 95.0 M $505 M
2025 Q1 233 94.0 M $834 M
2024 Q4 226 92.5 M $1.27 B
2024 Q3 251 91.3 M $2.50 B
2024 Q2 231 94.1 M $2.30 B
2024 Q1 194 97.3 M $2.07 B
2023 Q4 204 92.0 M $1.76 B
2023 Q3 195 82.7 M $1.33 B
2023 Q2 195 81.2 M $1.88 B
2023 Q1 198 82.3 M $1.91 B
2022 Q4 204 85.7 M $1.24 B
2022 Q3 200 81.6 M $1.56 B
2022 Q2 208 80.0 M $1.46 B
2022 Q1 217 79.1 M $1.99 B
2021 Q4 212 78.5 M $2.17 B
2021 Q3 222 79.3 M $2.56 B
2021 Q2 214 75.5 M $2.31 B
2021 Q1 206 73.9 M $2.25 B
2020 Q4 205 78.0 M $1.54 B
2020 Q3 209 78.5 M $1.02 B
2020 Q2 214 73.0 M $828 M
2020 Q1 212 73.9 M $1.06 B
2019 Q4 251 80.1 M $2.18 B
2019 Q3 246 78.3 M $2.24 B
2019 Q2 268 77.6 M $2.16 B
2019 Q1 288 78.8 M $2.62 B
2018 Q4 280 77.6 M $2.25 B
2018 Q3 311 77.5 M $3.56 B
2018 Q2 276 73.8 M $2.76 B
2018 Q1 278 75.6 M $2.23 B
2017 Q4 275 75.0 M $2.58 B
2017 Q3 243 75.3 M $2.72 B
2017 Q2 264 82.2 M $2.12 B
2017 Q1 257 84.4 M $1.62 B
2016 Q4 242 81.8 M $1.37 B
2016 Q3 242 82.7 M $1.70 B
2016 Q2 273 81.6 M $2.51 B
2016 Q1 245 81.9 M $3.07 B
2015 Q4 252 90.3 M $3.90 B
2015 Q3 255 91.2 M $3.42 B
2015 Q2 251 92.9 M $3.16 B
2015 Q1 270 93.2 M $3.49 B
2014 Q4 300 96.6 M $3.47 B
2014 Q3 304 96.8 M $3.94 B
2014 Q2 315 104 M $4.25 B
2014 Q1 314 109 M $3.95 B